Recent Security Class Actions

AlloVir Inc. Common Stock (NASDAQ: ALVR)

Company Name:AlloVir Inc. Common Stock
Stock Symbol:NASDAQ: ALVR
Class Period Start:03/22/2022
Class Period End (inclusive):12/21/2023
Filing Deadline:03/19/2024

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) the posoleucel Phase 3 Studies were unlikely to meet their primary endpoints; (ii) as a result, it was likely that the Company would ultimately discontinue the posoleucel Phase 3 studies; (iii) accordingly, AlloVir overstated the efficacy and clinical and/or commercial prospects of posoleucel; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.